Concepedia

William P. Hausdorff

WP

54

Publications

6.7K

Citations

34

H-Index

1986

Active since

Affiliations

GlaxoSmithKline (Belgium)(Current)

Howard Hughes Medical Institute

Duke University Hospital

Duke Medical Center

Université Libre de Bruxelles

William P. Hausdorff is an author at GlaxoSmithKline (Belgium) specializing in medicine, infection control, and signal transduction.

ORCID

Top concepts

Publications per year

1986–2023

54

Publications

54

Turning off the signal: desensitization of β‐adrenergic receptor function

William P. Hausdorff, Marc G. Caron, Robert J. Lefkowitz · The FASEB Journal · 1990 · 1.3K citations

Which Pneumococcal Serogroups Cause the Most Invasive Disease: Implications for Conjugate Vaccine Formulation and Use, Part I

William P. Hausdorff, John Bryant, Peter R. Paradiso et al. · Clinical Infectious Diseases · 2000 · 870 citations

, , +14

Removal of phosphorylation sites from the β2-adrenergic receptor delays onset of agonist-promoted desensitization

Michel Bouvier, William P. Hausdorff, Antonio De Blasi et al. · Nature · 1988 · 428 citations

, , +11

Phosphorylation Sites on Two Domains of the β2-Adrenergic Receptor Are Involved in Distinct Pathways of Receptor Desensitization

William P. Hausdorff, Michel Bouvier, Brian F. O’Dowd et al. · Journal of Biological Chemistry · 1989 · 411 citations · Full text

, , +18

Beta-adrenergic receptor sequestration. A potential mechanism of receptor resensitization.

Steven Yu, R J Lefkowitz, William P. Hausdorff · Journal of Biological Chemistry · 1993 · 393 citations · Full text

Rows per page

1–5 of 54